SOURCE: Alpharma Inc.

January 04, 2008 11:31 ET

Alpharma to Present at 26th Annual JP Morgan Healthcare Conference

BRIDGEWATER, NJ--(Marketwire - January 4, 2008) - Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that senior management will provide an overview of the company's business at the JP Morgan Healthcare Conference on Wednesday, January 9, 2008 at 7:30 am Pacific Time. The conference will be held at the Westin St. Francis Hotel in San Francisco.

This presentation will be webcast live and can be accessed through Alpharma's website, through its Investor Support and Company Calendar tabs.

An archived version will be available for 90 days through April 7, 2008 after the live presentation and can be accessed at the same location.

Alpharma press releases are also available at our website:

About Alpharma

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and an innovative pharmaceutical product pipeline that consists of several novel approaches to treat pain, including the FLECTOR® Patch (diclofenac epolamine topical patch), which is expected to launch in early 2008. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Contact Information

  • Contact:
    Jack Howarth
    Vice President, Investor Relations
    Email Contact

    Kathleen Makrakis
    Vice President
    Email Contact